Present a Poster and Save $50!
Cambridge Healthtech Institute encourages attendees to gain further exposure by presenting their work in the poster sessions. To secure a poster board and inclusion in the conference materials, your abstract must be submitted, approved and your registration paid in full by November 21, 2014.
Register online, or by phone, fax or mail. Please indicate that you would like to present a poster. Once your registration has been fully processed, we will send an email with a unique link and instructions for submitting your abstract using our online abstract submission tool. Please see below for more information.
Reasons you should present your research poster at this conference:
- Your poster will be exposed to our international delegation
- Receive $50 off your registration
- Your poster abstract will be published in our conference materials
- Automatically entered into poster competition
- Your research will be seen by leaders from top pharmaceutical, biotech, academic and government institutes
- You must select ONE track for your poster. (Your poster selection must be concurrent with your registration selection, but it does not have to be the same.)
- Your poster will hang only for the duration of your selected track.
- Late posters will only be accepted if space allows. Late posters will not be included in conference materials.
Note: Posters should be portrait orientation, with maximum dimensions of
36 inches wide (3 feet) x 48 inches high (4 feet).
* CHI reserves the right to publish your poster title and abstract in various marketing materials and products.
Click here for poster instructions and guidelines
Poster inquiries: firstname.lastname@example.org
A sample of the poster titles on display include:
A Community Genome-Scale Model of CHO Cell Metabolism for Multiomic Data Analysis and Bioprocess Design
A novel cell-free synthesis system based on CHO cell extract: Expression of membrane proteins and "difficult to express" proteins
A Novel Potent Antimicrobial Peptide, NKC as a Potential Topical Agent
ADAPT – a computational platform for antibody affinity maturation
Biophysical and Biochemical Studies of Calmodulin Binding to the Fas Death Domain as a Potential Therapeutic Target for Cancer Treatment
Bispecific Neutralizer Focusing of Doxorubicin to Carcinoembryonic Antigen–Expressing Colon Growth Cell Lines In Vitro and In Vivo
Cloning, Expression and Characterization of a Novel Mitochondria Associated Human Molecular Motor Myosin-XIX
Delineating the Functional Map of the Interaction Between Nimotuzumab and the Epidermal Growth Factor Receptor
Development and Pilot Plant Scale-up of a Lyophilized Thermostable Rotavirus Vaccine
Development and Validation of an Excel Based Secondary Drying Model
Engineering a Bispecific Protein from a Single-Domain, Bivalent Protein Scaffold
Engineering a Novel Multi-Specific Antagonist of Tumor-Associated Receptor Tyrosine Kinases
Enhanced DNA Delivery and Subsequent Plasmid Maintenance in a CHOK1SV Expression System for Improved Transient Recombinant Protein Yields
Epidemiological Characterization of Serotype Group B Streptococci Neonatal Infections Associated with Interleukin6 Level as a Sensitive Parameter for the Early Diagnosis of Infections
Evaluating Lyophilized Product Appearance in a Laboratory Setting
Exotoxin A and its urea depending cytotoxicity
Expression Strategies towards the Structural Determination of Membrane Proteins from Highly Infectious Agents
Generation & Production of Thermal Stable Affinity Reagents
High Throughput Screening of Protein Secretion in CHO Cells Using Split-GFP and Droplet Microfluidics
In Vitro Single DNA Molecule Expression in Drop-Based Microfluidics for the Study of Protein-Protein Interaction
Influence of Miscibility of Protein-Sugar Lyophilizates on Their Storage Stability
Investigation of Novel Powders Produced by Continuous Intensified Lyophilisation
Medical Molecular Farming: Transgenic Plants as Ideal Platform for Producing Therapeutic Proteins
Molecular Biophysical Characterization of Krr1p-ssDNA Complex
Molecular Biophysical Studies That Confirm Human Prp40 Homolog A as a Centrin Binding Protein
Novel Glycosylated VEGF Decoy Receptor Fusion Protein, VEGF-Grab, Efficiently Suppresses Tumor Angiogenesis and Progression
Optimization of Antibody Fc Effector Functions by In Vitro Glycoengineering
Polishing of Monoclonal Antibodies using a Polymer Grafted Cation Exchanger
Probing the Role of 192 Position in the Catalytic Mechanism of Human Paraoxonase 1: Site Specific Saturation Mutagenesis Studies
Purification and Characterization of a Soluble Leishmania donovani Nucleoside Hydrolase Recombinant Protein Expressed in Pichia pastoris
Silica-Based Affinity Purification Using Silica-Binding Tags
Simple, Rapid and Quantifiable In-Vivo Method to Detect Killing in Colicinogenic Sensitive E.coli
TAPBOOST Technology: Enhanced Production for Hard-to-Produce Proteins
The effect of FcγRI binding mutations on the structural flexibility of upper CH2 region of aglycosylated Fc
Theranostic applications of a tetravalent bispecific Ab against EGFR and HER2
Ubx as a Novel Protein-Based Material: Structural Insights, Functionalization via Protein Fusion, and Biomedical Applications
Using Microscopy FTIR to Determine Subvisible and Visible Particulates Identification
Using Time Course Metabolomics to Elucidate Genome-Scale Pathway Utilization for CHO-S Cell Lines in Batch Culture
Variation in Vial Heat Transfer Coefficients: A Case Study of Water Versus Product